Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Diabetes Drugs In DPP-4 Inhibitor Class Significantly Increase Risk Of Crohn’s Disease (CD)

February 11, 2019 By Law Offices of Thomas J. Lamb, P.A.

The medical journal Annals of Pharmacotherapy has published an article, “Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: A Meta-analysis”, which concludes that dipeptidyl peptidase-4 (DPP-4) inhibitors increase the risk of Crohn’s disease (CD). It goes on to point out that these DPP-4 inhibitor diabetes drugs, such as … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Crohn's Disease, dpp-4 drugs, drug side effects, Januvia, Kombiglyze, Onglyza

Current Number Of Lawsuits Filed In The Four Diabetes Drugs Federal Court MDL Cases

February 23, 2018 By Law Offices of Thomas J. Lamb, P.A.

From the February 15, 2018 version of this document, “MDL Statistics Report – Distribution of Pending MDL Dockets by Actions Pending” (accessed 2/21/18), published by the United States Judicial Panel on Multidistrict Litigation (JPML), we get the current number of cases filed in each of the four federal court Multidistrict Litigation (MDL) cases … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Byetta, Diabetic Ketoacidosis (DKA), Farxiga, Foot Amputation, Heart Failure, Invokamet, Invokana, Janumet, Januvia, Kombiglyze, Leg Amputation, Onglyza, Pancreatic Cancer, Toes Amputation, Victoza

Diabetes Drugs Kombiglyze And Onglyza MDL: Focus Is On Heart Failure

February 16, 2018 By Law Offices of Thomas J. Lamb, P.A.

A Kombiglyze and Onglyza MDL for federal court lawsuits filed against AstraZeneca and Bristol-Myers Squibb will focus on heart failure cases among other side effects associated with these diabetes drugs. As background, in April 2016 the FDA took regulatory action by mandating label changes with new warnings about an increased risk of heart … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury lawsuits, Heart Failure, Kombiglyze, Onglyza

Rhabdomyolysis May Be Linked To A New Class Of Oral Diabetes Medicines

October 16, 2017 By Law Offices of Thomas J. Lamb, P.A.

A class of diabetes drugs referred to as dipeptidyl peptidase-4 inhibitors may be associated with rhabdomyolysis, a side effect which involves severe muscle damage. In more detail, rhabdomyolysis is the breakdown of muscle tissue that leads to the release of muscle fiber contents into the blood. These substances are harmful to the kidney and … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Glyxambi, Janumet, Januvia, Jentadueto, Kazano, Kombiglyze, Nesina, Onglyza, Oseni, Qtern, Rhabdomyolysis, Tradjenta

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.